Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients

M.X.G. Draht, K.M. Smits, B. Tournier, V. Jooste, C. Chapusot, B. Carvalho, A.H.G. Cleven, S. Derks, K.A.D. Wouters, E.J.T.H. Belt, H.B.A.C. Stockmann, H. Bril, M.P. Weijenberg, P.A. van den Brandt, A.P. de Bruine, J.G. Herman, G.A. Meijer, F. Piard, V. Melotte, M. van Engeland

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)679-688
JournalMolecular oncology
Volume8
Issue number3
DOIs
Publication statusPublished - 2014

Cite this

Draht, M. X. G., Smits, K. M., Tournier, B., Jooste, V., Chapusot, C., Carvalho, B., ... van Engeland, M. (2014). Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular oncology, 8(3), 679-688. https://doi.org/10.1016/j.molonc.2014.01.011